ITC vs SUNPHARMA: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. ITC shows a lower P/E, a higher ROE and a higher dividend yield, while SUN PHARMACEUTICAL IND L shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ITC leads 8; SUNPHARMA leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ITC | SUNPHARMA |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Healthcare |
| Industry | Diversified FMCG | Pharmaceuticals |
Price
| Metric | ITC | SUNPHARMA |
|---|---|---|
| Live Price | ₹257.9 | ₹1,748 |
| Day Change | -0.39% | -0.57% |
| Volume | 1.76 Cr | 10.65 L |
| 52-Week High | ₹426.4 | ₹2,046.9 |
| 52-Week Low | ₹253.15 | ₹1,583.7 |
| Distance from 52W High | -39.52% | -14.6% |
Valuation
| Metric | ITC | SUNPHARMA |
|---|---|---|
| Market Cap | ₹3.22 L Cr | ₹4.18 L Cr |
| P/E Ratio | 16.24x | 34.58x |
| P/B Ratio | 4.44x | 5x |
| EPS | ₹3.51 | ₹12.06 |
| Book Value | ₹58.16 | ₹349.6 |
| Dividend Yield | 5.64% | 0.92% |
Growth
| Metric | ITC | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | -5% | 12.8% |
| EPS Growth (TTM YoY) | -72.7% | 25.6% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | ITC | SUNPHARMA |
|---|---|---|
| ROE | 29.02% | 13.72% |
| ROCE | 28.54% | 15.16% |
| Net Margin | 26% | 18.56% |
| Operating Margin | 32.94% | 26.44% |
| Debt to Equity | 0.03x | 0.05x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | ITC | SUNPHARMA |
|---|---|---|
| Promoter Holding | — | 52.68%▼ 1.8 pp |
| FII Holding | 33.22%▼ 1.01 pp | 14.36%▼ 0.17 pp |
| DII Holding | 49.82%▲ 0.69 pp | 22.27%▲ 0.09 pp |
| Public Holding | 16.93%▲ 0.33 pp | 10.7%▲ 1.89 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ITC and SUN PHARMACEUTICAL IND L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.